Hifas da Terra has more than 15 active clinical studies evaluating the health benefits of supplementation with its products, including two oncological clinical trials in patients with colorectal cancer (Micromarker project), breast cancer (Microimmunomama project), two highly innovative clinical trials in the area of women’s health and clinical studies in patients with SIBO in Irritable Bowel Syndrome, DAO deficiency and diverticular disease, among others.Hifas da Terra is Europe’s leading biotechnology company in the development of medicinal m...
| Sales markets | Central/South America; Eastern Europe; Western Europe |
|---|---|
| Affiliated categories: | Other Mushrooms |Dietary supplements |Immune Support More |